Vuno Future Growth
Future criteria checks 2/6
Vuno is forecast to grow earnings and revenue by 94.5% and 45.1% per annum respectively. EPS is expected to grow by 97.7% per annum. Return on equity is forecast to be 1% in 3 years.
Key information
94.5%
Earnings growth rate
97.7%
EPS growth rate
| Medical Equipment earnings growth | 40.9% |
| Revenue growth rate | 45.1% |
| Future return on equity | 1.0% |
| Analyst coverage | Low |
| Last updated | 06 Feb 2024 |
Recent future growth updates
No updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 36,850 | -2,000 | 8,600 | 11,600 | 2 |
| 12/31/2024 | 28,300 | -4,000 | -2,200 | 800 | 1 |
| 12/31/2023 | 13,276 | -15,627 | -15,931 | -15,550 | N/A |
| 9/30/2023 | 14,676 | -8,844 | -14,645 | -14,319 | N/A |
| 6/30/2023 | 11,942 | -11,186 | -17,001 | -16,705 | N/A |
| 3/31/2023 | 9,556 | -14,139 | -16,053 | -15,766 | N/A |
| 12/31/2022 | 8,275 | -15,662 | -16,595 | -16,282 | N/A |
| 9/30/2022 | 3,164 | -20,423 | -19,140 | -17,876 | N/A |
| 6/30/2022 | 2,656 | -20,263 | -18,216 | -16,809 | N/A |
| 3/31/2022 | 2,486 | -19,112 | -18,398 | -16,883 | N/A |
| 12/31/2021 | 2,248 | -19,556 | -16,412 | -14,797 | N/A |
| 9/30/2021 | 1,550 | -18,960 | -14,038 | -13,315 | N/A |
| 6/30/2021 | 1,425 | -17,520 | -10,202 | -9,507 | N/A |
| 12/31/2020 | 1,257 | -11,109 | -8,377 | -7,796 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: A338220 is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: A338220 is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: A338220 is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: A338220's revenue (45.1% per year) is forecast to grow faster than the KR market (9.1% per year).
High Growth Revenue: A338220's revenue (45.1% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: A338220's Return on Equity is forecast to be low in 3 years time (1%).